Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Comput Biol Chem ; 85: 107193, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32143021

ABSTRACT

VuLTP1.1, a LTP1 from Vigna unguiculata, inhibits 78.1 % of the human salivary α-amylase (HSA) activity at 20 µM. We had performed a correlation study between VuLTP1.1 structure and HSA inhibitory activity and showed that two VuLTP1.1 regions are responsible for HSA inhibition. In one of them we had characterized the crucial importance of an Arg39 for inhibition. In this work, we analyzed the VuLTP1.1-HSA interaction by protein-protein docking to understand the most probable interaction model and the mechanism of HSA inhibition by VuLTP1.1. The VuLTP1.1 tertiary structure quality and refinement as well as the docking assay between VuLTP1.1 and HSA were done by bioinformatic programs. HSA inhibition occurs by direct interaction of the VuLTP1.1 with the HSA causing the obstruction of the carbohydrate biding cleft with Gibbs free energy of -18.5 Kcal/mol and the dissociation constant of 2.6E-14 M. The previously identified Arg39 of VuLTP1.1 is burrowed into the active site of the HSA and there it interacts with the Asp300 of HSA catalytic site by a hydrogen bond. We had confirmed the importance of the Arg39 of VuLTP1.1 for the HSA inhibition which interacts with the Asp300 at the HSA active site. I-2, a LTP-like peptide, presents the same HSA inhibition pattern that VuLTP1.1, which indicates that the inhibition mechanism of the LTPs towards α-amylase is very similar. For the best of our knowledge, it is the first time that the HSA inhibition mechanism was understood and described for the LTP1s using VuLTP1.1 and I-2 as prototype inhibitors.


Subject(s)
Carrier Proteins/metabolism , Enzyme Inhibitors/pharmacology , Salivary alpha-Amylases/antagonists & inhibitors , Vigna/chemistry , Carrier Proteins/chemistry , Computational Biology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/metabolism , Humans , Models, Molecular , Salivary alpha-Amylases/metabolism
2.
PLoS One ; 9(6): e98966, 2014.
Article in English | MEDLINE | ID: mdl-24926801

ABSTRACT

Wolbachia pipientis, a maternally transmitted bacterium that colonizes arthropods, may affect the general aspects of insect physiology, particularly reproduction. Wolbachia is a natural endosymbiont of Aedes fluviatilis, whose effects in embryogenesis and reproduction have not been addressed so far. In this context, we investigated the correlation between glucose metabolism and morphological alterations during A. fluviatilis embryo development in Wolbachia-positive (W+) and Wolbachia-negative (W-) mosquito strains. While both strains do not display significant morphological and larval hatching differences, larger differences were observed in hexokinase activity and glycogen contents during early and mid-stages of embryogenesis, respectively. To investigate if glycogen would be required for parasite-host interaction, we reduced Glycogen Synthase Kinase-3 (GSK-3) levels in adult females and their eggs by RNAi. GSK-3 knock-down leads to embryonic lethality, lower levels of glycogen and total protein and Wolbachia reduction. Therefore, our results suggest that the relationship between A. fluviatilis and Wolbachia may be modulated by glycogen metabolism.


Subject(s)
Aedes/embryology , Aedes/microbiology , Glycogen/metabolism , Host-Parasite Interactions/physiology , Symbiosis/physiology , Wolbachia/physiology , Aedes/metabolism , Animals , Embryo, Nonmammalian/microbiology , Embryonic Development/physiology , Female , Glucose-6-Phosphate/metabolism , Glycogen Synthase Kinase 3/genetics , Male , Phylogeny , Wolbachia/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...